Related Experiment Video

Updated: Aug 14, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
07:54

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH

Published on: August 19, 2014

Recurring genetic aberrations in cancer cells: chromosomes as potential targets for nuclear medicine imaging

J D Rowley1

  • 1Department of Medicine, University of Chicago Medical Center, IL 60637-1470, USA.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|June 1, 1995
PubMed

Insights

Specific chromosomal aberrations in cancer cells can guide targeted therapies. Identifying these genetic changes using molecular probes may lead to new treatments for various cancers.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Neoplastic tumor cells exhibit specific chromosomal aberrations, including gains, losses, and translocations.
  • These genetic alterations are often unique to particular tumor types.
  • Understanding these aberrations is crucial for cancer research.

Purpose of the Study:

  • To highlight the specificity of chromosomal aberrations in neoplastic cells.
  • To explore the potential of molecular probes in identifying these aberrations.
  • To discuss the implications for designing targeted cancer therapies.

Main Methods:

  • Analysis of chromosomal aberrations in neoplastic tumor cells.
  • Utilizing molecular probes for aberration identification.
  • Review of existing literature on tumor-specific genetic alterations.

Main Results:

  • Chromosomal aberrations are characteristic of specific tumor types.
  • Molecular probes can effectively identify these genetic changes.
  • Aberrant genes present therapeutic targets.

Conclusions:

  • Chromosomal aberrations are valuable biomarkers for cancer classification.
  • Molecular probe technology offers a promising approach for detecting cancer-specific genetic alterations.
  • Targeting aberrant genes holds potential for developing novel, personalized cancer treatments.

More Related Videos

Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice10:14

Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice

Published on: January 11, 2017

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...